Finweek English Edition - - INVESTMENT -

Re­sults sea­son on the JSE has so far been about dis­ap­point­ment, with Dis­cov­ery be­ing an ex­cep­tion with HEPS growth of 20% ‒ good but not great. How­ever, what the mar­ket really en­joyed was a com­pany that not only to­tally un­der­stands its mar­ket but is ex­pand­ing the core of­fer­ing (Vi­tal­ity in par­tic­u­lar) to other parts of the world. Adrian Gore and his team are true dis­rup­tors, a phrase that gets bandied about far too of­ten, but they have taken a bor­ing grudge pur­chase and se­ri­ously shaken things up. Vi­tal­ity is at the front of this dis­rup­tion and the idea of tak­ing Vi­tal­ity as a stand-alone prod­uct into the US was one of their master strokes. The stock is sel­dom cheap by pretty much any met­ric one uses ‒ but equally it seems to never dis­ap­point.

Dis­cov­ery Lim­ited

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.